U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07420751) titled 'Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis' on Feb. 12.
Brief Summary: The goal of this clinical trial is to investigate the usability of auto-captioning glasses for adults diagnosed with NF2-related schwannomatosis and loss of hearing. The primary objective of the study is to determine the feasibility and acceptability of auto-captioning glasses in this population.
Participants will be asked to:
* Use the glasses at their discretion for 12 weeks
* Report their feedback at 3 and 12 week timepoints via online surveys and remote qualitative interviews
Study Start Date: Feb., 2026
...